ATE323166T1 - Fragmente der intron a von citomegalovirus - Google Patents

Fragmente der intron a von citomegalovirus

Info

Publication number
ATE323166T1
ATE323166T1 AT01979785T AT01979785T ATE323166T1 AT E323166 T1 ATE323166 T1 AT E323166T1 AT 01979785 T AT01979785 T AT 01979785T AT 01979785 T AT01979785 T AT 01979785T AT E323166 T1 ATE323166 T1 AT E323166T1
Authority
AT
Austria
Prior art keywords
fragments
intron
citomegalovirus
cytomegalovirus
cmv
Prior art date
Application number
AT01979785T
Other languages
English (en)
Inventor
Kent Thudium
Mark Selby
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE323166T1 publication Critical patent/ATE323166T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
    • C12N2840/445—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor for trans-splicing, e.g. polypyrimidine tract, branch point splicing

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Separation, Recovery Or Treatment Of Waste Materials Containing Plastics (AREA)
  • Perforating, Stamping-Out Or Severing By Means Other Than Cutting (AREA)
  • Package Closures (AREA)
AT01979785T 2000-10-13 2001-10-12 Fragmente der intron a von citomegalovirus ATE323166T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24050200P 2000-10-13 2000-10-13

Publications (1)

Publication Number Publication Date
ATE323166T1 true ATE323166T1 (de) 2006-04-15

Family

ID=22906778

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01979785T ATE323166T1 (de) 2000-10-13 2001-10-12 Fragmente der intron a von citomegalovirus

Country Status (11)

Country Link
US (2) US6893840B2 (de)
EP (1) EP1373524B1 (de)
JP (1) JP4445703B2 (de)
CN (1) CN1247785C (de)
AT (1) ATE323166T1 (de)
AU (1) AU2002211710A1 (de)
CA (1) CA2425852C (de)
DE (1) DE60118798T2 (de)
ES (1) ES2261489T3 (de)
WO (1) WO2002031137A2 (de)
ZA (1) ZA200302667B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0027088D0 (en) * 2000-11-06 2000-12-20 Glaxo Group Ltd DNA expression vectors
JP3630414B2 (ja) 2002-05-21 2005-03-16 インターナショナル・ビジネス・マシーンズ・コーポレーション 塩基配列のクラスタ生成システム、塩基配列のクラスタ生成方法、該クラスタ生成方法を実行するためのプログラム、および該プログラムを記憶したコンピュータ可読な記録媒体、および塩基配列情報提供システム
CA2528094A1 (en) * 2003-06-09 2005-01-13 Corixa Corporation Expression vectors for stimulating an immune response to cancer antigens
CA2542288A1 (en) * 2003-10-10 2005-04-21 Powderject Vaccines, Inc. Chimeric promoter comprising hcmv major immediate early gene exons and a heterologous intron
WO2005038020A1 (en) * 2003-10-14 2005-04-28 Biogen Idec Ma Inc. Flp-mediated recombination
GB0507997D0 (en) * 2005-02-01 2005-05-25 Powderject Vaccines Inc Nucleic acid constructs
EP1874929A2 (de) * 2005-04-22 2008-01-09 Lonza Biologics plc Säugerexpressionsvektor mit dem mcmv-promotor und dem ersten intron des major-immediate-early-gens von hcmv
EP2446034A4 (de) * 2009-06-22 2013-11-27 Ipca Lab Ltd Neue polynucleotidmoleküle zur verbesserten genexpression
JPWO2011027575A1 (ja) * 2009-09-04 2013-02-04 独立行政法人医薬基盤研究所 プロモーターのエンハンサーおよびその利用方法
US20120100573A1 (en) * 2010-10-21 2012-04-26 Thudium Kent B Cytomegalovirus intron a fragments
JP6482546B2 (ja) 2013-07-19 2019-03-13 ラリクス・バイオサイエンス・リミテッド・ライアビリティ・カンパニーＬａｒｉｘ Ｂｉｏｓｃｉｅｎｃｅ， Ｌｌｃ 二重対立遺伝子ノックアウトを生成するための方法および組成物
US11060083B2 (en) 2013-07-19 2021-07-13 Larix Bioscience Llc Methods and compositions for producing double allele knock outs
CA2942451A1 (en) * 2014-04-25 2015-10-29 Genethon Treatment of hyperbilirubinemia
WO2020014222A2 (en) 2018-07-09 2020-01-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Viral promoters and compositions and methods of use thereof
KR102798616B1 (ko) * 2019-12-20 2025-04-22 (주)셀트리온 목적 단백질의 고발현을 위한 인트론을 포함하는 발현 카세트 및 이의 이용
JP2023509118A (ja) 2019-12-24 2023-03-07 アスクレピオス バイオファーマシューティカル， インコーポレイテッド 調節性核酸配列
GB202005732D0 (en) 2020-04-20 2020-06-03 Synpromics Ltd Regulatory nucleic acid sequences
US20230250416A1 (en) 2020-07-06 2023-08-10 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Intron-encoded extranuclear transcripts for protein translation, rna encoding, and multi-timepoint interrogation of non-coding or protein-coding rna regulation
CN114958914B (zh) * 2022-06-06 2023-09-26 新乡医学院 一种人类及哺乳动物细胞附着体表达载体、构建方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939018A (en) * 1984-10-10 1999-08-17 Kawasaki Steel Corporation Martensitic stainless steels for seamless steel pipe
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
US5620896A (en) * 1992-03-23 1997-04-15 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
US5739018A (en) 1996-08-07 1998-04-14 The Regents Of The University Of California Packaging cell lines for pseudotyped retroviral vectors
US6025338A (en) * 1996-10-17 2000-02-15 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
ATE241965T1 (de) 1999-01-13 2003-06-15 Univ Johns Hopkins Med Genetische immunisierung mit gleichzeitiger verabreichung von nukleinsäuren und zytokinen
EP1200622A4 (de) 1999-07-06 2004-12-22 Merck & Co Inc Hiv impfstoff aus einem das gag-gen tragenden adenovirus

Also Published As

Publication number Publication date
EP1373524B1 (de) 2006-04-12
US6893840B2 (en) 2005-05-17
ZA200302667B (en) 2004-07-05
ES2261489T3 (es) 2006-11-16
CN1469930A (zh) 2004-01-21
CA2425852A1 (en) 2002-04-18
AU2002211710A1 (en) 2002-04-22
WO2002031137A2 (en) 2002-04-18
JP2004511229A (ja) 2004-04-15
US7846687B2 (en) 2010-12-07
US20050191727A1 (en) 2005-09-01
CA2425852C (en) 2009-09-29
EP1373524A2 (de) 2004-01-02
WO2002031137A3 (en) 2002-10-31
US20050079488A1 (en) 2005-04-14
CN1247785C (zh) 2006-03-29
DE60118798T2 (de) 2007-04-12
JP4445703B2 (ja) 2010-04-07
DE60118798D1 (de) 2006-05-24

Similar Documents

Publication Publication Date Title
ATE323166T1 (de) Fragmente der intron a von citomegalovirus
CY1113185T1 (el) Μεθοδοι συνενωσης αποδεκτη πεπτιδιου
DE69637816D1 (de) Der expression von genen, welche spezifisch sind für die stärkebiosynthese
MXPA02004666A (es) Gelatinas recombinantes.
WO2003011115A3 (en) Peptide-based multimeric targeted contrast agents
PL344475A1 (en) Bridged indenopyrrolocarbazoles
DE60128149D1 (en) Putrescin-n-methyltransferasepromotor
AU6114700A (en) Novel system for the sequential, directional cloning of multiple dna sequences
AU8738401A (en) Novel kallikrein gene
FI961666A7 (fi) Restenosiksen geeniterapia, jossa käytetään adenovirusvektoria
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
DK0817851T5 (da) DNA, der koder for humant papillomvirus type 18
AU2002212505A1 (en) Dna expression vectors
SG142300A1 (en) Promoters for expression in modified vaccinia virus ankara
MXPA02006167A (es) Promocion de la angiogenesis con survivina.
NO20003146L (no) Ketonperoksyd-derivater, deres fremstilling og anvendelse
AU7216498A (en) Inhibitors of the urokinase receptor
IL142596A0 (en) Baculovirus expression system
WO1995030757A3 (en) Metalloproteases from fusarium and aspergillus having thermolysin-like activity
NO20015330D0 (no) Ny promoter for genekspresjon
AU2001252591A1 (en) Novel promoters and gene expression method by using the promoters
AU6832498A (en) Substituted benzyl oximino compounds
ATE301721T1 (de) In vivo herstellung von replicativen molekülen
NO20020064L (no) Chlamysin B antibakterielt protein, gen som koder for dette samt et ekspresjonssystem for dette
DE69632205D1 (de) Herstellung von bacillus thuringiensis integrants

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1373524

Country of ref document: EP